Laxmin Laxminarain
Vermögen: - $ am 31.10.2026
Vermögen: - $ am 31.10.2026
Prattipati Laxminarain is currently Director at Oculogica, Inc. since 2018, Director at Millar, Inc. since 2018, Independent Director at Microbot Medical, Inc. since 2017, Director at GT Medical Technologies, Inc. since 2019, and Operating Advisor at Revival Healthcare Capital LLC.
Former roles include Chief Executive Officer at Deinde Medical Corp.
and President & Director at Cerenovus, Inc. from 2006 to 2017.
Education includes an MBA from Indian Institute of Management Ahmedabad and an undergraduate degree from Osmania University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MICROBOT MEDICAL INC -.--% | 01.04.2026 | 0 ( -.--% ) | - $ | 31.10.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MICROBOT MEDICAL INC. | Direktor/Vorstandsmitglied | 06.12.2017 |
Millar, Inc.
Millar, Inc. Medical SpecialtiesHealth Technology Develops pressure sensing technologies for medical devices | Direktor/Vorstandsmitglied | 05.12.2018 |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical equipment for the treatment of brain tumors | Direktor/Vorstandsmitglied | 31.01.2019 |
Oculogica, Inc.
Oculogica, Inc. Medical SpecialtiesHealth Technology Develops eye-tracking based neurodiagnostics to detect concussion and traumatic brain injury | Direktor/Vorstandsmitglied | 01.04.2018 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 - 1000 million and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of pharmaceuticals, biotech, drug development and discovery & healthcare services. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Berater | - |
| Unternehmen | Position | Ende |
|---|---|---|
Cerenovus, Inc.
Cerenovus, Inc. Medical SpecialtiesHealth Technology Develops and markets diagnostic and therapeutic products | Präsident | 01.01.2017 |
Deinde Medical Corp.
Deinde Medical Corp. Medical/Nursing ServicesHealth Services Provides healthcare services | Vorstandsvorsitzender | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 9 |
|---|---|
Oculogica, Inc.
Oculogica, Inc. Medical SpecialtiesHealth Technology Develops eye-tracking based neurodiagnostics to detect concussion and traumatic brain injury | Health Technology |
Cerenovus, Inc.
Cerenovus, Inc. Medical SpecialtiesHealth Technology Develops and markets diagnostic and therapeutic products | Health Technology |
Indian Institute of Management Ahmedabad
Indian Institute of Management Ahmedabad Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osmania University
Osmania University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millar, Inc.
Millar, Inc. Medical SpecialtiesHealth Technology Develops pressure sensing technologies for medical devices | Health Technology |
Microbot Medical, Inc.
Microbot Medical, Inc. BiotechnologyHealth Technology Specializes in the research, design, development and commercialization of micro-robotics assisted medical technologies | Health Technology |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical equipment for the treatment of brain tumors | Health Technology |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 - 1000 million and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of pharmaceuticals, biotech, drug development and discovery & healthcare services. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Finance |
Deinde Medical Corp.
Deinde Medical Corp. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Bitte wählen Sie Ihre Edition
Alle länderspezifischen Finanzinformationen